Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Novel use of radiotracer reveals extent of mycoardial infarction damage


Investigators reporting at the 49th Annual Meeting of the Society of Nuclear Medicine (SNM) have determined that a noninvasive nuclear medicine technique can accurately and safely detect the extent of persistent heart muscle damage after a heart attack. In two studies, researchers reported on the safety and efficacy 201Tl/99mTc Annexin (ApomateTM) SPECT in detecting and localizing myocardial tissue damage and revealing areas of persistent cellular injury. SPECT (single-photon emission computed tomography) is a nuclear medicine procedure that uses the injection of a radiotracer to produce three-dimensional computer-reconstructed images that reveal information about both structure and function.

In one study, Neil Steinmetz, MD, and colleagues from eight medical centers in the U.S. and Canada reported on the use of 201Tl/99mTc Annexin SPECT in 59 patients who had experienced a myocardial infarction (MI) within the previous 96 hours. 81% of these patients showed persistent myocardial tissue injury on imaging. Even in patients who had been successfully revascularized (blood flowing normally to the heart), the 201Tl/99mTc Annexin SPECT revealed areas of persistent cellular damage. In a second study, Raymond Taillefer, MD, and colleagues from the Centre Hospitalier de l’Université de Montréal (Canada), provided additional evidence that this imaging procedure is effective during the first 4 days after an MI.

Apomate (Theseus Imaging, Boston, MA) is a radiopharmaceutical originally developed for imaging cell death (apoptosis and necrosis) as an early indicator of response to anticancer treatment. The studies reported at the SNM meeting are part of a larger effort to use Apomate and nuclear medicine techniques to determine the extent and location of myocardial cellular injury after an infarction and the response to treatment. Evidence presented at the SNM meeting suggests that Annexin SPECT is safe and effective in detecting persistent areas of damage and diagnosing the extent of past myocardial injury in patients who have experienced MIs. Using this information, physicians may be able to tailor treatment plans and lifestyle changes to the specific needs of each patient Myocardial infarction is the medical term for a heart attack and results when the supply of oxygen is cut off to some portion of the heart muscle. The American Heart Association estimates that more than a million Americans will experience a heart attack in 2002, and more than 300,000 American will die of sudden cardiac arrest.

The Society of Nuclear Medicine Annual Meeting is being held June 15–19 at the Los Angeles Convention Center, Los Angeles, CA. In addition to educational sessions, the meeting will focus on leading medical developments in the field of nuclear medicine, including radioimmunotherapy with a new class of drugs that target cancer, diagnostic breakthroughs with PET, and other topics. More than 5,000 specialists in the field of nuclear medicine, including scientists, technologists, researchers, and representatives from the medical industry, are expected to attend. The Society of Nuclear Medicine is an international scientific and professional organization with more than 13,000 members dedicated to promoting the science, technology, and practical applications of nuclear medicine. The SNM is based in Reston, VA.

For late-breaking news about the world of nuclear medicine and events at the 49th Annual Society of Nuclear Medicine meeting, visit

Abstract 11. Sunday, June 16, 3:06–3:18 p.m. Room 410
Simultaneous Dual Isotope 201Tl/99mTc-Annexin (ApomateTM) SPECT in Detection of Acute Myocardial Infarction: Initial Results of a Phase II Multicenter
N. Steinmetz, R. Taillefer, R. C. Hendel, F. L. Weiland, D.S. Berman, M.I. Travin, M. Fish, M.E. Mallett, and A.M. Green Main contact:
Neil Steinmetz MD

Abstract 15. Sunday, June 16, 4:15–4:27 p.m. Room 410
99mTc-Annexin V Scintigraphy in Detection of Acute Myocardial Infarction (MI): Repeat Imaging After the Onset of Acute Symptoms in Order to Evaluate the Persistence of Abnormal Radiotracer Uptake
R. Taillefer, D.C. Phaneuf, D.H. Duong, C. Benjamin, S. Lajeunesse, A. Gagnon, A.M. Green, N.D. Steinmetz
Contact author: R. Taillefer
Centre Hospitalier de l’Université de Montréal
Montréal, PQ, Canada


Karen Lubieniecki | EurekAlert

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

A new kind of quantum bits in two dimensions

19.03.2018 | Physics and Astronomy

Scientists have a new way to gauge the growth of nanowires

19.03.2018 | Materials Sciences

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Science & Research
Overview of more VideoLinks >>>